228 related articles for article (PubMed ID: 36167400)
21. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
22. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.
Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA
Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
[TBL] [Abstract][Full Text] [Related]
24. Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma.
Yang HW; Kim TM; Song SS; Shrinath N; Park R; Kalamarides M; Park PJ; Black PM; Carroll RS; Johnson MD
Neoplasia; 2012 Jan; 14(1):20-8. PubMed ID: 22355270
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N
Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.
Kim JH; Lee SH; Rhee CH; Park SY; Lee JH
J Neurooncol; 1998 Nov; 40(2):101-6. PubMed ID: 9892091
[TBL] [Abstract][Full Text] [Related]
27. Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review.
Okano A; Miyawaki S; Teranishi Y; Ohara K; Hongo H; Sakai Y; Ishigami D; Nakatomi H; Saito N
Neurol Med Chir (Tokyo); 2022 Aug; 62(8):347-360. PubMed ID: 35871574
[TBL] [Abstract][Full Text] [Related]
28. NF2 status of meningiomas is associated with tumour localization and histology.
Kros J; de Greve K; van Tilborg A; Hop W; Pieterman H; Avezaat C; Lekanne Dit Deprez R; Zwarthoff E
J Pathol; 2001 Jul; 194(3):367-72. PubMed ID: 11439370
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features.
Goutagny S; Bah AB; Henin D; Parfait B; Grayeli AB; Sterkers O; Kalamarides M
Neuro Oncol; 2012 Aug; 14(8):1090-6. PubMed ID: 22711605
[TBL] [Abstract][Full Text] [Related]
30. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
[TBL] [Abstract][Full Text] [Related]
31. Allelic losses in neurofibromatosis 2-associated meningiomas.
Lamszus K; Vahldiek F; Mautner VF; Schichor C; Tonn J; Stavrou D; Fillbrandt R; Westphal M; Kluwe L
J Neuropathol Exp Neurol; 2000 Jun; 59(6):504-12. PubMed ID: 10850863
[TBL] [Abstract][Full Text] [Related]
32. Genomic Landscape of Meningiomas.
Wang JZ; Nassiri F; Mawrin C; Zadeh G
Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
[TBL] [Abstract][Full Text] [Related]
33.
Sakai Y; Miyawaki S; Teranishi Y; Okano A; Ohara K; Hongo H; Ishigami D; Shimada D; Mitsui J; Nakatomi H; Saito N
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804955
[TBL] [Abstract][Full Text] [Related]
34. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E
Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal and genetic abnormalities in benign and malignant meningiomas using DNA microarray.
Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
Neurol Res; 2005 Oct; 27(7):747-54. PubMed ID: 16197812
[TBL] [Abstract][Full Text] [Related]
37. NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study.
Buccoliero AM; Castiglione F; R Degl'Innocenti D; Gheri CF; Garbini F; Taddei A; Ammannati F; Mennonna P; Taddei GL
Neuropathology; 2007 Feb; 27(1):36-42. PubMed ID: 17319281
[TBL] [Abstract][Full Text] [Related]
38. [The molecular genetics of meningiomas and genotypic/phenotypic correlations].
Dezamis E; Sanson M
Rev Neurol (Paris); 2003 Sep; 159(8-9):727-38. PubMed ID: 13679715
[TBL] [Abstract][Full Text] [Related]
39. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
40. Genetic and epigenetic alterations in meningiomas.
Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
